Beyaert R - Search Results

1

Unusual Lipid A from a Cold-Adapted Bacterium: Detailed Structural Characterization.

Casillo A, Ziaco M, Lindner B, Parrilli E, Schwudke D, Holgado A, Verstrepen L, Sannino F, Beyaert R, Lanzetta R, Tutino ML, Corsaro MM. Casillo A, et al. Among authors: beyaert r. Chembiochem. 2017 Sep 19;18(18):1845-1854. doi: 10.1002/cbic.201700287. Epub 2017 Jul 27. Chembiochem. 2017. PMID: 28650563

2

LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation.

Wullaert A, Verstrepen L, Van Huffel S, Adib-Conquy M, Cornelis S, Kreike M, Haegman M, El Bakkouri K, Sanders M, Verhelst K, Carpentier I, Cavaillon JM, Heyninck K, Beyaert R. Wullaert A, et al. Among authors: beyaert r. J Biol Chem. 2007 Jan 5;282(1):81-90. doi: 10.1074/jbc.M607481200. Epub 2006 Nov 6. J Biol Chem. 2007. PMID: 17088249 Free article.

3

Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.

Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM, Beyaert R. Verstrepen L, et al. Among authors: beyaert r. J Cell Mol Med. 2008 Jan-Feb;12(1):316-29. doi: 10.1111/j.1582-4934.2007.00187.x. Epub 2007 Dec 10. J Cell Mol Med. 2008. PMID: 18081698 Free PMC article.

4

TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme.

Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R. Verstrepen L, et al. Among authors: beyaert r. Cell Mol Life Sci. 2008 Oct;65(19):2964-78. doi: 10.1007/s00018-008-8064-8. Cell Mol Life Sci. 2008. PMID: 18535784 Free article. Review.

5

Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation.

Verhelst K, Verstrepen L, Coornaert B, Carpentier I, Beyaert R. Verhelst K, et al. Among authors: beyaert r. Methods Mol Biol. 2009;517:205-15. doi: 10.1007/978-1-59745-541-1_13. Methods Mol Biol. 2009. PMID: 19378032

6

ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.

Verstrepen L, Carpentier I, Verhelst K, Beyaert R. Verstrepen L, et al. Among authors: beyaert r. Biochem Pharmacol. 2009 Jul 15;78(2):105-14. doi: 10.1016/j.bcp.2009.02.009. Epub 2009 Feb 27. Biochem Pharmacol. 2009. PMID: 19464428 Review.

7

Expression, biological activities and mechanisms of action of A20 (TNFAIP3).

Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R. Verstrepen L, et al. Among authors: beyaert r. Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. doi: 10.1016/j.bcp.2010.06.044. Epub 2010 Jul 3. Biochem Pharmacol. 2010. PMID: 20599425 Review.

8

TAX1BP1, a ubiquitin-binding adaptor protein in innate immunity and beyond.

Verstrepen L, Verhelst K, Carpentier I, Beyaert R. Verstrepen L, et al. Among authors: beyaert r. Trends Biochem Sci. 2011 Jul;36(7):347-54. doi: 10.1016/j.tibs.2011.03.004. Epub 2011 May 4. Trends Biochem Sci. 2011. PMID: 21546252 Review.

9

Linear ubiquitination in NF-κB signaling and inflammation: What we do understand and what we do not.

Verhelst K, Verstrepen L, Carpentier I, Beyaert R. Verhelst K, et al. Among authors: beyaert r. Biochem Pharmacol. 2011 Nov 1;82(9):1057-65. doi: 10.1016/j.bcp.2011.07.066. Epub 2011 Jul 20. Biochem Pharmacol. 2011. PMID: 21787758

10

No ubiquitin anchors and fully RIGged.

Verstrepen L, Beyaert R. Verstrepen L, et al. Among authors: beyaert r. Immunity. 2012 Jun 29;36(6):897-9. doi: 10.1016/j.immuni.2012.06.005. Immunity. 2012. PMID: 22749347 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page